We should stop with the discussion of getting LL in Florida MAB centers. At this point in time LL is not an approved drug for COVID. We don’t need another episode like the badgering of the FDA which caused them to issue that letter. That letter hurt the prospects of LL in the US and abroad (Dr’s are more hesitant to request compassionate use now) and it hurt the stock price which hurts fundraising and uplisting efforts.
Let bug CYDY to get the BLA filed more quickly and accurately and the long haulers final report published and the phase 3 trial long haulers trial approved and the 2 Brazil trials enrolled. Those will all help more and are things the company can work on.
IMO